Prolific Machines Receives Grant to Develop a Platform to Produce Affordable Monoclonal Antibodies to Prevent Infectious Disease in Low- and Middle-Income Countries
Prolific Machines will apply its optogenetics expertise to enable reproducible biomanufacturing solutions that create global access to life-saving drugs for vulnerable populations in low- and middle-income countries (LMICs).